Efficacy of bepridil to prevent ventricular fibrillation in severe form of early repolarization syndrome.
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Goro
G
Katsuumi
Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan; Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
Wataru
W
Shimizu
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Electronic address: hiroshi7@med.niigata-u.ac.jp.
Hiroshi
H
Watanabe
Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Takashi
T
Noda
Division of Heart Rhythm Management, Yokohama Rosai Hospital, Yokohama, Japan.
Akihiko
A
Nogami
Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Kimie
K
Ohkubo
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takeru
T
Makiyama
Department of Internal Medicine, Division of Cardiovascular Respiratory and Neurology, Asahikawa Medical University, Asahikawa, Japan.
Naofumi
N
Takehara
Department of Internal Medicine, Division of Cardiovascular Respiratory and Neurology, Asahikawa Medical University, Asahikawa, Japan.
Yuichiro
Y
Kawamura
Department of Cardiology, Niigata City General Hospital, Niigata, Japan.
Yukio
Y
Hosaka
Cardiovascular Center, Tachikawa General Hospital, Nagaoka, Japan.
Masahito
M
Sato
Departments of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Satoki
S
Fukae
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Masaomi
M
Chinushi
Department of Cardiology, Niigata City General Hospital, Niigata, Japan.
Hirotaka
H
Oda
Cardiovascular Center, Tachikawa General Hospital, Nagaoka, Japan.
Masaaki
M
Okabe
Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Japan.
Akinori
A
Kimura
Departments of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Koji
K
Maemura
Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Ichiro
I
Watanabe
Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Shiro
S
Kamakura
Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Shiga, Japan.
Minoru
M
Horie
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yoshifusa
Y
Aizawa
Molecular Physiology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Naomasa
N
Makita
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Tohru
T
Minamino
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015764:Bepridil / Q000494:pharmacology / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D015764:Bepridil
Arrhythmia; Bepridil; Electrocardiogram; Treatment; Ventricular fibrillation